Non-compressive sleeves versus compression stockings after total knee arthroplasty: A prospective pilot study.
T Elaine Justice, Paul B Jacob
https://pubmed.ncbi.nlm.nih.gov/38094981/Actively Recruiting
Led by Endocrine Research Solutions · Updated on 2025-02-25
80
Participants Needed
1
Research Sites
N/A
Total Duration
Distal symmetric polyneuropathy, also called diabetic neuropathy, is a common nerve complication of diabetes that affects the longest nerve fibers, especially in the toes and feet. It causes sensory loss, pain, and increases the risk of foot ulcers and amputations, which lowers quality of life. This condition is usually not reversible, and current management focuses on slowing its progression and preventing complications. The study aims to evaluate the use of semiconductor embedded therapeutic socks in managing this condition over a 12-week rehabilitation period. The study compares the effects of semiconductor embedded therapeutic socks, which emit mid and far infrared waves and negative ions to improve blood flow and reduce inflammation, against placebo socks that do not contain this fabric. Participants will wear these socks during the 12-week treatment phase. The socks technology is believed to activate biological pathways that reduce pain and inflammation locally, unlike systemic treatments. The study will collect outcome measures at standard intervals to assess the socks impact on diabetic neuropathy symptoms and function. Participants will be assessed before and after treatment using specific questionnaires and physical exams to measure function, pain, symptom severity, and foot tissue oxygenation. Compliance with sock use will be monitored weekly. The primary outcome is improved patient function measured by standardized scales over 12 weeks. Secondary outcomes include pain reduction, symptom improvement, and better blood oxygen levels in the feet. The study is randomized, double-blind, and will last at least 12 weeks for each participant.
CONDITIONS
Clinical Outcomes Related to Treatment of Distal Symmetric Polyneuropathy Using Semiconductor Embedded Therapeutic Socks
J
Jessica Tapia
K
Korie Miles
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Endocrine Research Solutions
Lead Sponsor
INCREDIWEAR HOLDINGS, INC.
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Semiconductor Embedded Therapeutic Socks | Placebo Socks |
|---|---|---|
| What it is | Specialized socks embedded with semiconductor fabric thought to emit infrared energy for therapeutic effects. | Socks identical in appearance but without semiconductor material, serving as placebo control. |
| Role in trial | Investigational arm; participants randomized to wear the therapeutic socks aimed at improving symptoms and function. | Control arm; participants randomized to wear socks that look identical but lack the therapeutic fabric. |
| Primary use | To test whether wearing the socks improves lower leg function, reduces neuropathy symptoms, and enhances quality of life in diabetic neuropathy. | To provide a control group for comparison, helping determine device efficacy against symptoms and function changes attributable to wearing socks without active material. |
| How it is given or performed | Participants are instructed to wear the semiconductor socks as directed over a 12-week period. | Participants are instructed to wear placebo socks under identical conditions. |
| Evidence status | Evidence for this specific semiconductor sock is not yet established in published studies for diabetic neuropathy. Far-infrared and functional fabrics have been suggested to affect pain and circulation, but definitive results in this population are pending trial outcomes. | No expected therapeutic effect. Placebo control is important for distinguishing genuine device benefit from the act of wearing socks. |
| Important limitations | Effectiveness for neuropathy remains unproven outside this trial. Results may depend on device wear time and adherence. Broader evidence for infrared-emitting socks is limited. | Placebo socks lack therapeutic properties; may not account for all psychological or wear-related effects experienced by participants. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants wear semiconductor embedded therapeutic socks or placebo socks to manage symptoms of diabetic neuropathy and improve blood circulation and pain relief.
Weekly visits for up to 12 weeks
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
T Elaine Justice, Paul B Jacob
https://pubmed.ncbi.nlm.nih.gov/38094981/Jung-Hyun Park, Sangmi Lee, Du-Hyong Cho...
https://pubmed.ncbi.nlm.nih.gov/23756809/Jan Kyselovic, Jozef Masarik, Hayet Kechemir...
https://pubmed.ncbi.nlm.nih.gov/35510621/Su Youn Cho, Youn Sun Roh, Hee Tae Roh
https://pubmed.ncbi.nlm.nih.gov/27390434/K D Modi, A K Sharma, S K Mishra...
https://pubmed.ncbi.nlm.nih.gov/9025011/Saurabh P Mehta, Allison Fulton, Cedric Quach...
https://pubmed.ncbi.nlm.nih.gov/26813750/Zhi-Rong Jia, Ting-Ting Wang, Hong-Xia Wang
https://pubmed.ncbi.nlm.nih.gov/25271682/Etta J Vinik, Risa P Hayes, Alan Oglesby...
https://pubmed.ncbi.nlm.nih.gov/15929681/Zohaib Iqbal, Shazli Azmi, Rahul Yadav...
https://pubmed.ncbi.nlm.nih.gov/29709457/Katherine Marino, Rachel Lee, Paul Lee
https://pubmed.ncbi.nlm.nih.gov/31696136/Endocrine Research Solutions
Lead Sponsor
INCREDIWEAR HOLDINGS, INC.
Collaborating Sponsor